Synthesis and characterization of a peripherally restricted CB(1) cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice

Cannabinoid CB(1) receptor antagonists reduce body weight in rodents and humans, but their clinical utility as anti-obesity agents is limited by centrally mediated side effects. Here, we describe the first mixed CB(1) antagonist/CB(2) agonist, URB447 ([4-amino-1-(4-chlorobenzyl)-2-methyl-5-phenyl-1H...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: LoVerme, Jesse, Duranti, Andrea, Tontini, Andrea, Spadoni, Gilberto, Mor, Marco, Rivara, Silvia, Stella, Nephi, Xu, Cong, Tarzia, Giorgio, Piomelli, Daniele
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3690177/
https://ncbi.nlm.nih.gov/pubmed/19128970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2008.12.059
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak